Skip to main content
. 2019 Dec 10;30(12):1036–1043. doi: 10.5152/tjg.2019.18334

Table 3.

Baseline Characteristics on univariate analysis with esophageal variceal bleeding

Parameters No Esophageal Variceal Bleeding (n=141) Esophageal Variceal Bleeding (n=61) p
Age (in years) 43.18±9.07 45.13±11.71 0.2503
Alcohol consumption per day (in grams) 76.39±44.6 101.93±51.75 0.0011
Duration of alcohol intake (in years) 12.14±3.85 12.80±3.23 0.2109
Hemoglobin (g/dL) 8.74±2.3 7.32±1.82 <0.001
Total leukocyte count (103/μL) 7650 (5560–10060) 6580 (4440–9600) 0.1660 a
Platelets (109/L) 160 (117–232) 124 (53–80) <0.001 a
Total Bilirubin (mg/dL) 2.60 (1.3–4.9) 2.60 (1.6–4) 0.0720 a
Total protein (g/dL) 6.66±0.71 6.26±0.92 0.0034
Serum albumin (g/dL) 2.85±0.46 2.70±0.43 0.0303
Alanine aminotransferase (ALT) (U/L) 30 (22–43) 29 (21–50) 0.4678 a
Aspartate aminotransferase (AST) (U/L) 66 (44–91) 63 (40–103) 0.5281 a
Creatinine (mg/dL) 1.11±0.74 1.21±0.65 0.3252
Spleen Bipolar Diameter (mm) 13.06±2.58 13.45±2.23 0.2329
CTP score 9.94±2.16 11.05±1.65 0.0001
MELD 16.06±6.1 16.69±5.3 0.4652
AAR 2.23±1.27 2.15±1.02 0.6533
APRI 1.19±1.26 2.75±3.96 0.0037
FIB-4 3.90±3.35 7.98±7.24 0.0001
PC/SD ratio 1200 (878–1867) 630 (443–910) <0.001 a
a

p-values from Mann-Whitney’s U test. All other p-values from Student’s t-test.

CTP score: Child-Turcotte-Pugh score; MELD: model for end-stage liver disease; AAR: aspartate-aminotransferase-to-alanine-aminotransferase (AST-to-ALT) ratio; APRI: AST-to-platelet-ratio index; FIB-4: fibrosis-4-index; PC/SD: platelet-count-to-spleen-diameter ratio.